Article Details

Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results

Retrieved on: 2018-03-22 04:03:45

Tags for this article:

Click the tags to see associated articles and topics

Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results. View article details on hiswai:

Excerpt

<div>2017 included $1.9 million of equity compensation expense related to the acceleration of employee <b>equity stock</b> and option award vesting triggered by the sale of the Company's PCT subsidiary to Hitachi. The net loss from continuing operations for the twelve months ended December 31, 2017 was ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo